• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • Outsourcing Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

machine learning

Living cells illustration Cells membrane with nucleus are floating Medical and science concept background 3D render
Biotech

After $1B fundraise, Xaira breaks silence on AI work

Xaira’s Chief Operating Officer, Jeff Jonker, opened up to Fierce, divulging details about the biotech’s efforts in I&I research.
Gabrielle Masson , Darren Incorvaia Mar 17, 2026 2:52pm
Rise increase upward trajectory arrow ascent ascending
Favicon Fierce Pharma

Teva debuts innovation platform to parry key industry challenges

Nov 19, 2025 8:38am
A doctor with a graphic representation of the lungs

Thermo Fisher launches biopsy test to assess lung rejection risk

Oct 9, 2025 10:50am
Singapore skyline at sunset

Singapore drug discovery platform heads to Nasdaq via SPAC deal

Oct 2, 2025 9:50am
Space rocket moon explore

PhaseV launches trial optimization software into CRO's services

Sep 10, 2025 12:54pm
bowel

GI-focused CRO boosts trial tech with adaptive software

Feb 3, 2025 11:40am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings